Skip to content

Comparison of Skin Incision Closure Material for the Transobturator Suburethral Sling Procedure

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01313754
Enrollment
160
Registered
2011-03-14
Start date
2011-05-31
Completion date
2012-12-31
Last updated
2013-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Postoperative, Irritation (Physical), Pelvic Pain

Keywords

Skin closure, dermabond, vicryl, monocryl, Suburethral sling, Transobturator Sling, Pain, Discomfort, Skin irritation

Brief summary

The purpose of this study is to compare different skin closure materials for the transobturator suburethral sling procedure. Currently the investigators are using monocryl suture material as the standard for skin closure. This material has anecdotally show to be very irritating to patients who have had this type of surgery. Our study will compare the monocryl suture material with vicryl (polyglactin 910) and dermabond (2-octyl cyanoacrylate) skin glue. The investigators believe that vicryl suture material will be superior in comfort when compared to monocryl and dermabond for this type of procedure.

Interventions

PROCEDUREVicryl Suture

Vicryl suture material will be placed on the patients left sided incision.

PROCEDUREDermabond

Dermabond skin glue will be placed on the patients left sided incision.

Sponsors

Loma Linda University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Those patients receiving a transobturator suburethral sling procedure. * Adults (\>= 18years).

Exclusion criteria

* Non-English speaking. * Allergy to monocryl, vicryl, or dermabond.

Design outcomes

Primary

MeasureTime frame
The level of severity of patient discomfort at their incision sites.The patients will be assessed at their second week post operative visit.

Secondary

MeasureTime frame
Cosmesis at the incision sitesThe patients will be assessed at their 2nd week post operative visit

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026